Arkolith/Insider Trading/EDIT/Form 4

O'Neill Gilmore Neil

CEO, DirectorEditas Medicine, Inc. (EDIT) · full profile →Form 4 · filed Dec 5, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3K
Net Open-Market Flow
-$3K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 3, 2024Sell(S)2K$2.08$3K312K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001650664-24-000126) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML